Spillover Effects of Medical Innovations: A Universal and Scalable Approach to Measure the Societal Value of Avoided Informal Care Time.

Kesimpta (ofatumumab subcutaneous) - Novartis, Genmab

http://www.ncbi.nlm.nih.gov/pubmed/42758459

Adnan Atitallah; Diego Hernandez; Eva Levi; Lena Steinbeck; Malina Müller; Platon Peristeris; Rebecca Grün

Sep 19, 2026